Daniel Stauder
Stock Analyst at JMP Securities
(4.46)
# 332
Out of 5,044 analysts
19
Total ratings
66.67%
Success rate
19.52%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Stauder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AORT Artivion | Maintains: Market Outperform | $42 → $47 | $45.65 | +2.96% | 6 | Oct 10, 2025 | |
| ATRC AtriCure | Reiterates: Market Outperform | $60 | $34.01 | +76.44% | 6 | Apr 30, 2025 | |
| STIM Neuronetics | Maintains: Market Outperform | $3 → $7 | $2.70 | +159.26% | 1 | Mar 5, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $88.44 | +24.38% | 4 | Feb 28, 2025 | |
| AXON Axon Enterprise | Reiterates: Market Outperform | $725 | $738.88 | -1.88% | 1 | Feb 26, 2025 | |
| AVNS Avanos Medical | Reiterates: Market Perform | n/a | $11.14 | - | 1 | May 7, 2024 |
Artivion
Oct 10, 2025
Maintains: Market Outperform
Price Target: $42 → $47
Current: $45.65
Upside: +2.96%
AtriCure
Apr 30, 2025
Reiterates: Market Outperform
Price Target: $60
Current: $34.01
Upside: +76.44%
Neuronetics
Mar 5, 2025
Maintains: Market Outperform
Price Target: $3 → $7
Current: $2.70
Upside: +159.26%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $88.44
Upside: +24.38%
Axon Enterprise
Feb 26, 2025
Reiterates: Market Outperform
Price Target: $725
Current: $738.88
Upside: -1.88%
Avanos Medical
May 7, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $11.14
Upside: -